Sequent Scientific Limited (SEQUENT.NS) NSE

195.00

+8.28(+4.43%)

Updated at September 17 12:01PM

Currency In INR

Sequent Scientific Limited

Address

Dosti Pinnacle

Mumbai, 400604

India

Phone

91 22 4111 4777

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

1195

First IPO Date

March 10, 2016

Key Executives

NameTitlePayYear Born
Mr. Rajaram NarayananMD, Chief Executive Officer & Director31.18M1968
Mr. Phillip TrottAssoc. Vice President, Head of Legal & Chief Risk Officer840,000N/A
Mr. Saurav BhalaChief Financial Officer6.52MN/A
Mr. Prasad LadVice President of HR & Administration0N/A
Mr. Ravi NairExecutive Vice President of Human Resources & Administration0N/A
Mr. Vedprakash RagateExecutive Director0N/A
Ms. Yoshita VoraCompany Secretary & Compliance Officer0N/A
Mr. Ramesh Kumar PillaiCorporate Vice President of Ra Qa and Technical Services01965
Mr. Abhishek SinghalHead of Investor Relations0N/A

Description

Sequent Scientific Limited engages in the animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) and finished dosage formulations in the areas of feed supplements, antibiotics, anthelmintics, antibacterial, anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It offers analytical solutions that supports API, pharmaceutical, personal care, and nutraceutical organizations, as well as provides method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to Sequent Scientific Limited in October 2009. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited operates as a subsidiary of CA Harbor Investments.